484 related articles for article (PubMed ID: 32820252)
1. LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1.
Li C; Zhao W; Pan X; Li X; Yan F; Liu S; Feng J; Lu J
Oncogene; 2020 Sep; 39(39):6157-6171. PubMed ID: 32820252
[TBL] [Abstract][Full Text] [Related]
2. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
3. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
[TBL] [Abstract][Full Text] [Related]
5. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
Fu J; Cai H; Wu Y; Fang S; Wang D
Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FAS-AS1 inhibits the progression of non-small cell lung cancer through regulating miR-19a-5p.
Yang CB; Xiao SW; Cheng SM; Zhang C
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3775-3785. PubMed ID: 32329854
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
Li Q; Jiang B; Qi Y; Zhang H; Ma H
Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
[TBL] [Abstract][Full Text] [Related]
9. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086
[TBL] [Abstract][Full Text] [Related]
10. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
11. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
Wang M; Liao Q; Zou P
Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
Yu Z; Wang G; Zhang C; Liu Y; Chen W; Wang H; Liu H
Cell Cycle; 2020 Feb; 19(3):300-316. PubMed ID: 31928130
[No Abstract] [Full Text] [Related]
13. LncRNA KTN1-AS1 facilitates esophageal squamous cell carcinoma progression via miR-885-5p/STRN3 axis.
Chen L; Lu J; Li X; Wang X; Qiao R; Guo W; Ren Q
Genes Genomics; 2024 Feb; 46(2):241-252. PubMed ID: 37747640
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway.
Du LJ; Mao LJ; Jing RJ
Biochem Biophys Res Commun; 2020 Dec; 533(3):565-572. PubMed ID: 32981678
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Li YY; Li W; Chang GZ; Li YM
Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
